Find Academic Supervisors

Katy K. TsaiView profile

Assistant Clinical Professor

• Medical Oncology
• Melanoma
• Skin Cancer
• +7 more

Dr. Katy K. Tsai is a clinical faculty member at the University of California, San Francisco (UCSF), affiliated with the School of Medicine and the Department of Medicine. She serves in the Melanoma & Skin Cancer Program as a medical oncologist and Site Committee Chair, where she plays a key role in developing clinical trials and curating the program's research portfolio. BA in Comparative Literature, Brown University (2006) MD, Brown University (2010) Residency in Internal Medicine, University of North Carolina at Chapel Hill (2013) Fellowship in Medical Oncology, UCSF (2016), where she served as chief fellow Dr. Tsai's research is centered on improving outcomes for melanoma patients, with a focus on melanoma survivorship and the understanding and management of immune-related adverse events (irAEs) , including cardiovascular, gastrointestinal, and fatigue syndromes. Her work bridges clinical oncology and translational science, aiming to enhance both efficacy and safety of immunotherapies. The 15 most recent articles reflect a strong emphasis on immunotherapy , checkpoint inhibitors , melanoma brain metastases , and toxicity management . Her publications include pivotal clinical trials (e.g., POLARIS), molecular profiling studies, and contributions to major clinical guidelines (NCCN, ASCO). The research spans from single-cell immunology to population-level symptom burden during the pandemic, demonstrating a broad and integrative approach. Her scientific awards include: Research Honors in Urogynecology, Brown University (2010) Chairman's Award in Department of Medicine, UNC Chapel Hill (2013) ASCO/AACR Workshop on Clinical Cancer Research Methods (2014) ASCO Travel Award for Meritorious Abstract (2015) SITC Young Investigator Travel Award (2016) Dr. Tsai is actively involved in mentoring and collaborative research, frequently working with multidisciplinary teams across oncology, dermatology, surgery, and cardio-oncology. While no formal advising roles are listed, her leadership in clinical trials and guideline development indicates a significant role in training and shaping future research. She is not associated with a named lab but contributes to the broader research ecosystem at UCSF, particularly within the Helen Diller Family Comprehensive Cancer Center (HDFCCC).

Harish VasudevanView profile

Physician Scientist

• Neurofibromatosis
• Nervous system tumors
• Receptor tyrosine kinase signaling
• +3 more

Dr. Harish Vasudevan is a physician scientist at the University of California San Francisco (UCSF), holding joint appointments in the Departments of Radiation Oncology and Neurological Surgery. His research focuses on neurofibromatosis and nervous system tumors, particularly investigating oncogenic growth factor signaling through receptor tyrosine kinases and the Ras pathway to identify novel therapeutic strategies. Education: PhD in Medicine/Neuroscience from Mount Sinai School of Medicine (2017), MD, and BS in Biology from Caltech (2009) Research highlights include molecular profiling of melanoma brain metastases, epigenetic reprogramming in schwannomas, and spatial genomic analysis of meningiomas. Current projects supported by the Department of Defense and Children's Tumor Foundation aim to clarify Ras GAP specificity and develop NF1 reconstitution therapies. Selected Awards: SNO Adult Basic Research Abstract Award (2017), Roentgen Resident/Fellow Research Award (2022-2025), Francis Collins Scholar Award (2022) Dr. Vasudevan's collaborative work spans brain metastasis atlases, radiation-immunotherapy synergy, and neurogenetic imaging-genomics correlations. His publications demonstrate expertise in genomic analysis, spatial transcriptomics, and clinical outcomes research.

• Bacteriophage Therapy
• Antimicrobial Resistance
• Protein Engineering
• +3 more

Niels Vander Elst is a Postdoctoral Researcher at the Department of Neuroscience, Karolinska Institutet, affiliated with the Neuro-infections & Neuroinflammation research group led by Federico Iovino. He specializes in bacteriophage-derived endolysins as innovative antimicrobials to combat antibiotic-resistant infections, particularly in Gram-positive pathogens such as Streptococcus and Staphylococcus . Dr. Vander Elst holds a dual PhD in Biotechnology and Veterinary Medicine from KU Leuven and Ghent University, funded by the Research Foundation Flanders (FWO), and conducted research at the University of Maryland under a fellowship from the Belgian American Educational Foundation (BAEF). His research focuses on: Bacteriophage therapy and endolysin engineering Antibiotic resistance reversal mechanisms Neuro-infections and blood-brain barrier penetration Veterinary applications of antimicrobials Protein engineering and synthetic biology approaches His publications demonstrate a progression from veterinary applications toward human medical innovations, with recent work focusing on restoring antibiotic susceptibility in resistant pathogens and treating central nervous system infections. Earlier research established foundational work on bovine mastitis therapeutics. Honors include: Finalist for University of Maryland's 'Invention of the Year' (2020) Award recipient at the Encephalitis Meeting in London (2024) Significant grants supporting his work: Kronprinsessan Lovisas Förening (2023, 2025): Endolysins for pneumococcal meningitis treatment Fonds Wetenschappelijk Onderzoek (2020-2023): Engineering endolysins for bovine mastitis Belgian American Educational Foundation (2019): Bacteriophage-endolysin therapy development Beyond research, Dr. Vander Elst teaches neurohistology in KI's medical curriculum, serves in the Junior Faculty Leadership, and promotes open science initiatives. He actively communicates scientific advancements through public outreach articles on phage-based antimicrobials.

Natalia DeMarcoView profile

Associate Professor

• Neurodevelopment
• Inhibitory Neurons
• Cortical Circuit Assembly
• +2 more

Natalia DeMarco is an Associate Professor of Neuroscience at the Feil Family Brain & Mind Research Institute, Weill Cornell Medical College. Her lab investigates how genetic programs and neuronal activity interact during early brain development, focusing on inhibitory interneurons and their role in neurological disorders like autism, schizophrenia, and epilepsy. PhD, Columbia University (2007) Postdoctoral Fellowship, Patterson Trust (2009) DeMarco’s research explores mechanisms behind excitatory/inhibitory imbalance in the brain, using mouse models to study: Neurotransmitter roles (glutamate, GABA) in interneuron maturation Electrophysiology and viral tracing for circuit analysis Developmental origins of cortical connectivity Implications for autism, schizophrenia, and epilepsy Her 15 most recent publications (2023–2002) highlight trends in cortical circuit assembly, GABA signaling, and interneuron dysfunction. Keywords span neuroscience, genetics, and neurodevelopmental disorders, with subfields like synaptic connectivity, mouse genetics, and activity-dependent plasticity. Scientific awards include: K99/R00 Pathway to Independence Award (2012) Leon Levy Fellowship (2016) Irma Hirschl Career Scientist Award (2020) 2023 Paper of the Year (Babij, Ferrer et al.) DeMarco mentors MD/PhD students (e.g., Andrew Iannone, Rachel Babij) and collaborates with institutions like NYU, Stony Brook, and INSERM. Her lab, located in Manhattan, utilizes techniques such as optogenetics and in vivo imaging to study cortical development. Grants include R01 funding from NIMH and NINDS.

• Biomedical Engineering
• Physiological Measurement
• Cardiovascular Health
• +3 more

Elisa Mejía-Mejía is a researcher at City, University of London , specializing in Biomedical Engineering with a focus on Photoplethysmography (PPG) signal analysis for cardiovascular monitoring. Her work bridges Physiological Measurement and Signal Processing , with key publications in Frontiers in Physiology , Biomedical Signal Processing and Control , and npj Digital Medicine . Developed PRV analysis protocols for Intracranial Pressure Monitoring (2023) Validated In-Vitro Tissue-Vessel Phantoms for PPG research (2020-2022) Created Outlier Management Frameworks for PPG data (2022) Her 15+ publications (2020-2023) demonstrate expertise in PRV/HRV relationships , blood pressure estimation , and optical sensor development . She collaborates with Prof. Panicos Kyriacou and has presented at IEEE EMBC and Sensors conferences.

Charles S BockmanView profile

Assistant Professor

• Pharmacology
• Neuroscience
• Drug Addiction
• +4 more

Charles S Bockman is an Assistant Professor in the Department of Pharmacology and Neuroscience at Creighton University School of Medicine. His research focuses on the role of extrinsic stimuli in drug addiction, particularly neuroplastic responses to environmental enrichment, aiming to develop novel treatments for substance misuse. Academic Focus: Pharmacology, Neuroscience, Receptor Signaling Key Themes: Environmental Enrichment, Nicotinic Receptors, Adrenergic Regulation Email: CharlesBockman@creighton.edu

• Phenotypic assays for drug discovery
• Fibroproliferative diseases
• Erectile dysfunction
• +4 more

Selim Cellek is Professor of Health and Biomedicine at Anglia Ruskin University (ARU), where he leads the Drug Discovery Group within the Medical Technology Research Centre (MTRC). He is affiliated with the Faculty of Health, Medicine and Social Care, specifically the School of Allied Health and Social Care. His research bridges pharmacology, urology, and translational medicine. Education: MD, Hacettepe University PhD Pharmacology, University of London Research Focus: Professor Cellek specializes in phenotypic drug discovery, fibroproliferative diseases, and urogenital pathophysiology. Key areas include diabetic autonomic neuropathy, Peyronie’s disease, nitrergic neurotransmission, and the development of cell-based assays for novel therapeutics. Publication Trends: His 15 most recent articles (2009–2015) concentrate on urogenital disorders (erectile dysfunction, Peyronie’s disease), diabetic complications, and gastrointestinal pharmacology. Methodologically, they emphasize translational models, drug discovery assays, and neurovascular mechanisms. Awards & Fellowships: Fellowship, British Pharmacological Society Fellowship, European Society for Sexual Medicine Professional Engagement: He consults for the pharmaceutical industry on drug development for urogenital, gastrointestinal, and diabetic neuropathy indications.

Brent HarperView profile

Associate Professor

• Sports Physical Therapy
• Concussion Assessment
• Chronic Ankle Instability
• +5 more

Dr. Brent Harper is an Associate Professor in the Department of Physical Therapy at Crean College of Health and Behavioral Sciences, Chapman University , with over 15 years of academic and clinical experience. His work bridges clinical practice, research, and education in physical therapy, focusing on sports injury prevention, concussion assessment, and chronic ankle instability. Education: Doctor of Science (Andrews University), Doctor of Physical Therapy (Western University of Health Sciences), Master of Physical Therapy (Loma Linda University), and dual Bachelor degrees (Southern College) Research Interests revolve around: Concussion diagnostics using neurocognitive and autonomic assessments Biomechanical analysis of dynamic balance and postural control Manual therapy applications for vestibular and chronic pain conditions Technology integration in portable reaction time and gait analysis tools Publication Trends show a focus on musculoskeletal injury prediction through movement screening, sex-specific performance differences , and multimodal concussion testing . Recent work explores non-invasive neuromodulation and cost-effective diagnostic methods . Academic Contributions include: Key studies on chronic ankle instability and postural control Pioneering research using stroboscopic glasses and smartphone apps for balance assessment Critical appraisals of manual therapy efficacy and dry cupping interventions Prominent presentations at APTA , ACSM , and CPTA conferences

Marc NoppenView profile

Professor

• Hospital Management
• Public Health Systems
• Pulmonology
• +4 more

Marc Noppen serves as Professor at Vrije Universiteit Brussel's School of Public Health, specializing in hospital management and clinical sciences with particular expertise in thoracic conditions. His research integrates artificial intelligence applications with traditional clinical approaches to address complex healthcare system challenges in Belgium and internationally. His research interests span hospital management systems, public health policy development, and clinical pulmonary medicine with specific focus on pneumothorax treatments and thoracic surgical innovations. Noppen's work bridges clinical practice with healthcare administration, examining how technological advancements can optimize hospital operations while maintaining high-quality patient care standards. Recent publications demonstrate evolving research trajectories from traditional thoracic surgery topics toward contemporary challenges including pandemic response systems, AI implementation in clinical settings, and future healthcare modeling. His 2020-2022 work particularly addresses post-COVID recovery mechanisms, home healthcare innovations, and end-of-life care protocols within Belgian university hospitals. Noppen actively mentors doctoral and master's students, supervising thesis work on topics ranging from air pollution health impacts to clinical surgical techniques. His advisory role extends to doctoral juries and master's thesis defenses, contributing to the development of next-generation healthcare professionals. Professional activities include regular participation in healthcare policy discussions, media engagements with major Belgian outlets like Knack and Roularta, and leadership roles in conferences addressing critical healthcare challenges including talent management in medical fields and circular economy applications in hospital settings.

Robert TomsakView profile

Clinical Professor

• Neuro-Ophthalmology
• Eye Movement Disorders
• Optic Nerve Diseases
• +4 more

Robert Tomsak is a Clinical Professor at the School of Medicine , Wayne State University , specializing in Neuro-Ophthalmology . He completed his Medical School at Case Western Reserve University School of Medicine, followed by Ophthalmology Residency at Cleveland Clinic Foundation and a Neuro-Ophthalmology Fellowship under Dr. J. Lawton Smith at Bascom Palmer Eye Institute, University of Miami. Clinical Interests: Neuro-ophthalmology, eye movement disorders, cortical visual disturbances, optic nerve diseases, headaches, visual field abnormalities, idiopathic intracranial hypertension Research Contributions: Pioneering work in acquired nystagmus treatments (e.g., tenotomy combined with memantine), optical coherence tomography for optic nerve diseases, and visual disturbances in Alzheimer's His recent publications focus on fourth nerve palsy diagnostics , pediatric pseudotumor cerebri , and OCT in multiple sclerosis . Collaborations include researchers like Leigh, Rucker, and Bienfang. Notable techniques include combining eye muscle surgery with pharmacological interventions for nystagmus management.

Jessica S PlavickiView profile

Associate Professor

• cardiac
• cardiovascular
• Neuroscience
• +4 more

Jessica S Plavicki is an Associate Professor of Pathology and Laboratory Medicine at Brown University. Her research intersects cardiovascular biology , neurovascular diseases , and toxicology , with a focus on zebrafish models to study the impact of environmental pollutants on development. Education: PhD, University of Wisconsin at Madison (2009) BA, University of Texas at Austin (2000) Her work explores how environmental toxicants like dioxin affect neural connectivity , cardiac development , and vascular biology , using zebrafish as a model organism. She also investigates the role of AHR signaling in neurovascular and cardiac developmental processes, and has developed transgenic reporter lines to study gene function. Recent publications highlight trends in neurotoxicology , developmental toxicology , and cardiovascular research , with a strong emphasis on zebrafish models and environmental pollutants such as dioxin and perfluorinated compounds. Scientific Awards: Graduate School Faculty Award for Advising & Mentoring, Brown University (2023) New-Career Scientist Award, Society of Toxicology (2023) National Institute of Environmental Health Sciences Outstanding New Environmental Scientist Award (2020) Young Investigator Award, Midwest Regional Chapter of the Society of Toxicology (2012) She has received grants including the NIH Pre-doctoral Trainee Fellowship and has mentored numerous students. Her collaborations with Kurt Pennell (School of Engineering) and others reflect interdisciplinary work in environmental health and toxicology .

Darci R. BlockView profile

Research Professor

• Clinical Chemistry
• Laboratory Informatics
• Body Fluid Analysis
• +2 more

Darci R. Block, Ph.D. , is a Clinical Chemist at Mayo Clinic Rochester, Minnesota, with a focus on Laboratory Medicine and Pathology . She contributes to research and education, specializing in body fluid testing, process optimization, and clinical informatics. Research Interests: Validation of assays for body fluid analysis Improving clinical lab efficiency and quality Laboratory informatics systems Biomarker variability and diagnostic accuracy Scientific Contributions: Developed analytical validation frameworks for body fluid chemistry Investigated interference effects in clinical assays Advanced autoverification systems in core laboratories Scientific Awards & Memberships: Board-certified in Clinical Chemistry (American Board of Clinical Chemistry) Diplomate, American Medical Informatics Association (AMIA) Active leadership in AACC Academy and Association for Diagnostics & Laboratory Medicine

Rebecca L. KingView profile

Professor

• Lymphoma
• Hematopathology
• Pediatric hematopathology
• +4 more

Dr. Rebecca L. King is a Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic College of Medicine in Rochester, Minnesota. She serves as Program Director of the Hematopathology Fellowship Program and has held multiple leadership positions within professional societies including Treasurer of the Society for Hematopathology Executive Committee (2024-2026) and Interactive Microscopy Lead for the United States and Canadian Academy of Pathology. Dr. King completed her medical education at University of Pennsylvania School of Medicine (2007), followed by residency training in Anatomic and Clinical Pathology at Hospital of the University of Pennsylvania (2011), where she served as Chief Resident. She completed her Hematopathology Fellowship at Mayo Clinic College of Medicine in 2012. Her undergraduate studies were at Bucknell University where she earned a BS in Biology with a minor in Chemistry (2002). Her research focuses on lymphoma diagnostics and classification, with particular expertise in follicular lymphoma, diffuse large B-cell lymphoma, and rare lymphoid disorders. Dr. King has made significant contributions to lymphoma classification systems and has published extensively on the molecular characteristics of B-cell malignancies. Her work bridges diagnostic pathology with clinical outcomes, helping to refine lymphoma subtyping for improved patient care. She has been instrumental in developing consensus guidelines for lymphoma diagnosis and treatment through her involvement with the International Consensus Classification of Myeloid and Lymphoid Neoplasms. Dr. King's recent publications demonstrate a consistent focus on refining lymphoma classification systems, understanding treatment resistance mechanisms, and improving diagnostic criteria for various lymphoid malignancies. Her work spans molecular biology, clinical epidemiology, and diagnostic pathology, with an emphasis on translating research findings into practical clinical applications. She frequently collaborates with multidisciplinary teams to address complex diagnostic challenges in hematopathology. Among her notable recognitions are the Lodato Award for leadership, teaching, and contribution to the residency program (2011) and Alpha Omega Alpha Medical Honor Society membership (2007). She has received multiple undergraduate honors including Phi Beta Kappa and the President's Award for Distinguished Academic Achievement (2002). Dr. King actively mentors fellows and residents, having served as Mentor for Hematopathology and HemeOnc Fellow Conference (2014-2020) and as a member of the MCASOM Student Promotions and Assessment Committee. She co-directs Hematopathology Grand Rounds and contributes to multiple national guideline committees including the National Comprehensive Cancer Network B-cell lymphoma Guidelines Committee. Her leadership extends to the International Consensus Classification of Myeloid and Lymphoid Neoplasms as an Invited Contributor to the Clinical Advisory Committee. She maintains active involvement in multiple research initiatives including the Eastern Cooperative Oncology Group Lymphoma Core Committee and the European Association of Hematopathology, where she serves as Co-Chair. Her work on neurolymphomatosis, Richter transformation, and follicular lymphoma subtypes represents cutting-edge research at the intersection of diagnostic pathology and clinical oncology.

Andrew McKeonView profile

Professor

• Autoimmune Neurology
• Neuroimmunology
• Multiple Sclerosis
• +3 more

Andrew McKeon is a Professor of Neurology and Laboratory Medicine and Pathology at Mayo Clinic College of Medicine and Science in Rochester, Minnesota. He co-directs the Neuroimmunology Laboratory and specializes in immune-mediated central nervous system diseases, including autoimmune encephalitis, ataxias, movement disorders, paraneoplastic syndromes, and stiff-person syndrome. Certified by the American Board of Medical Laboratory Immunology, he focuses on antibody biomarker discovery, clinical trials, and diagnostic criteria development. MD, Neuroimmunology (2011) - University College Dublin Autoimmune Neurology Fellowship (2009) - Mayo Clinic Movement Disorders Fellowship (2007) - Mayo Clinic MB BCh/BAO (2000) - University College Dublin His research centers on autoimmune neurological disorders , with three major domains: Diagnostic Innovation: Developing criteria for paraneoplastic syndromes and autoimmune encephalitis while addressing misdiagnosis challenges Biomarker Discovery: Validating novel antibodies like GAD65 and MOG through laboratory research Clinical Trials: Testing therapeutic approaches for stiff-person syndrome and other autoimmune CNS conditions Recent publications highlight: 2024 review on autoimmune seizure disorders 2024 analysis of paraneoplastic movement disorders 2023 diagnostic criteria for stiff-person spectrum disorders Scientific honors include: Grass Foundation-American Neurological Association Award (2013) Top 5% abstract at American Academy of Neurology (2009) Department of Neurology Clinical Research Award (2008) As co-director of Mayo's Neuroimmunology Laboratory, he leads both clinical service development and multi-institutional research collaborations. His work bridges laboratory medicine and neurology through 15+ years of clinical research at Mayo Clinic.

Michael F MyersView profile

Clinical Professor

• Physician Health
• Suicide
• Psychotherapy
• +8 more

Dr. Michael F. Myers, MD, is a Clinical Professor of Psychiatry at SUNY Downstate Health Sciences University's College of Medicine . He serves as the Medical Student Ombudsperson and Co-Chair of the Learning Environment Committee , with a career spanning over 35 years in academic psychiatry and private practice. His work focuses on physician health and suicide prevention , bridging clinical expertise with advocacy. Dr. Myers earned his medical degree from the Schulich School of Medicine & Dentistry at Western University, Canada, followed by residencies at USC Los Angeles County General Hospital , Detroit General Hospital , and University of British Columbia . He holds licenses in California (until 2027) and New York (until 2025), and is board-certified in Psychiatry and Neurology by the American Board. His research spans physician suicide , stigma in mental health , and marital therapy , with recent publications analyzing pandemic impacts on maternal/infant mental health and suicide prevention strategies. Dr. Myers' 150+ articles emphasize the intersection of clinical practice, gender dynamics, and ethical medical education. Notable awards include Distinguished Life Fellowships from the American and Canadian Psychiatric Associations Special Commendation from the American Psychiatric Association (2022) Honorary Member Award from Doctors of British Columbia (2015) CAIR Resident Well-Being Award (2002) He lectures globally and consults on physician mental health, including independent medical evaluations and resilience training . Dr. Myers advises medical trainees and professionals, having previously served as Vice-Chair of Education and Director of Training at SUNY Downstate. His clinical teaching includes courses on psychotherapy, suicide prevention , and physician well-being . While no formal lab or team details are mentioned, his advocacy work with the American Foundation for Suicide Prevention and editorial roles (e.g., Bellevue Literary Review ) highlight his commitment to systemic change.